Calcium in PDB 4bty: Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
Enzymatic activity of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
All present enzymatic activity of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors:
1.4.3.21;
Protein crystallography data
The structure of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors, PDB code: 4bty
was solved by
E.Bligt-Linden,
M.Pihlavisto,
I.Szatmari,
Z.Otwinowski,
D.J.Smith,
L.Lazar,
F.Fulop,
T.A.Salminen,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
49.20 /
3.10
|
Space group
|
P 65 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
226.736,
226.736,
218.160,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
18.42 /
24.638
|
Other elements in 4bty:
The structure of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
(pdb code 4bty). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 4 binding sites of Calcium where determined in the
Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors, PDB code: 4bty:
Jump to Calcium binding site number:
1;
2;
3;
4;
Calcium binding site 1 out
of 4 in 4bty
Go back to
Calcium Binding Sites List in 4bty
Calcium binding site 1 out
of 4 in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca1763
b:71.6
occ:1.00
|
O
|
A:LEU530
|
2.3
|
79.0
|
1.0
|
OD1
|
A:ASP673
|
2.3
|
62.7
|
1.0
|
OD1
|
A:ASP531
|
2.3
|
76.0
|
1.0
|
O
|
A:LEU674
|
2.3
|
74.6
|
1.0
|
OD1
|
A:ASP529
|
2.4
|
75.9
|
1.0
|
N
|
A:LEU674
|
3.2
|
75.5
|
1.0
|
C
|
A:LEU530
|
3.3
|
81.1
|
1.0
|
C
|
A:LEU674
|
3.3
|
72.5
|
1.0
|
CG
|
A:ASP673
|
3.5
|
70.1
|
1.0
|
CG
|
A:ASP531
|
3.5
|
83.6
|
1.0
|
CG
|
A:ASP529
|
3.7
|
78.4
|
1.0
|
ND2
|
A:ASN537
|
3.8
|
70.7
|
1.0
|
C
|
A:ASP673
|
3.8
|
79.3
|
1.0
|
CA
|
A:LEU674
|
3.9
|
74.9
|
1.0
|
NZ
|
A:LYS106
|
3.9
|
77.1
|
1.0
|
CA
|
A:ASP673
|
4.0
|
77.9
|
1.0
|
N
|
A:ASP531
|
4.0
|
81.2
|
1.0
|
CA
|
A:ASP531
|
4.0
|
83.5
|
1.0
|
C
|
A:ASP529
|
4.1
|
74.4
|
1.0
|
N
|
A:LEU530
|
4.2
|
75.8
|
1.0
|
O
|
A:LEU535
|
4.2
|
89.0
|
1.0
|
O
|
A:ASP529
|
4.3
|
77.6
|
1.0
|
CA
|
A:LEU530
|
4.4
|
77.7
|
1.0
|
CB
|
A:ASP673
|
4.4
|
75.5
|
1.0
|
CB
|
A:ASP531
|
4.4
|
85.5
|
1.0
|
OD2
|
A:ASP673
|
4.4
|
65.8
|
1.0
|
N
|
A:VAL675
|
4.4
|
68.2
|
1.0
|
OD2
|
A:ASP531
|
4.5
|
80.2
|
1.0
|
OD2
|
A:ASP529
|
4.5
|
78.5
|
1.0
|
CA
|
A:ASP529
|
4.5
|
72.8
|
1.0
|
O
|
A:ASP673
|
4.7
|
78.6
|
1.0
|
CB
|
A:ASP529
|
4.7
|
72.7
|
1.0
|
CB
|
A:LEU674
|
4.8
|
79.3
|
1.0
|
CA
|
A:VAL675
|
4.9
|
69.1
|
1.0
|
CD2
|
A:LEU535
|
4.9
|
73.1
|
1.0
|
|
Calcium binding site 2 out
of 4 in 4bty
Go back to
Calcium Binding Sites List in 4bty
Calcium binding site 2 out
of 4 in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca1764
b:94.5
occ:1.00
|
OE2
|
A:GLU667
|
2.3
|
0.2
|
1.0
|
O
|
A:PHE663
|
2.3
|
89.2
|
1.0
|
OE2
|
A:GLU572
|
2.4
|
89.0
|
1.0
|
OD1
|
A:ASN665
|
2.5
|
0.0
|
1.0
|
OE1
|
A:GLU572
|
3.1
|
0.9
|
1.0
|
CD
|
A:GLU572
|
3.1
|
86.5
|
1.0
|
CG
|
A:ASN665
|
3.3
|
92.0
|
1.0
|
CD
|
A:GLU667
|
3.3
|
0.7
|
1.0
|
C
|
A:PHE663
|
3.4
|
81.1
|
1.0
|
OE1
|
A:GLU641
|
3.5
|
87.7
|
1.0
|
ND2
|
A:ASN665
|
3.5
|
91.4
|
1.0
|
NZ
|
A:LYS638
|
3.7
|
95.2
|
1.0
|
OE2
|
A:GLU641
|
4.0
|
85.8
|
1.0
|
CA
|
A:PHE663
|
4.1
|
79.6
|
1.0
|
OG1
|
A:THR635
|
4.1
|
68.7
|
1.0
|
OE1
|
A:GLU667
|
4.1
|
90.3
|
1.0
|
CG
|
A:GLU667
|
4.1
|
95.5
|
1.0
|
CD
|
A:GLU641
|
4.2
|
90.5
|
1.0
|
CG2
|
A:THR635
|
4.3
|
80.0
|
1.0
|
N
|
A:GLN636
|
4.4
|
81.9
|
1.0
|
O
|
A:GLN636
|
4.5
|
85.2
|
1.0
|
N
|
A:ILE664
|
4.5
|
82.6
|
1.0
|
N
|
A:ASN665
|
4.6
|
86.1
|
1.0
|
CG
|
A:GLU572
|
4.7
|
84.8
|
1.0
|
CB
|
A:THR635
|
4.7
|
74.0
|
1.0
|
CB
|
A:ASN665
|
4.7
|
91.1
|
1.0
|
CB
|
A:GLN636
|
4.7
|
83.6
|
1.0
|
CA
|
A:ILE664
|
4.7
|
82.0
|
1.0
|
CB
|
A:PHE663
|
4.7
|
82.1
|
1.0
|
CE
|
A:LYS638
|
4.8
|
87.5
|
1.0
|
CD
|
A:LYS638
|
4.9
|
87.5
|
1.0
|
|
Calcium binding site 3 out
of 4 in 4bty
Go back to
Calcium Binding Sites List in 4bty
Calcium binding site 3 out
of 4 in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca1763
b:72.1
occ:1.00
|
OD1
|
B:ASP673
|
2.3
|
74.2
|
1.0
|
O
|
B:LEU530
|
2.3
|
86.1
|
1.0
|
O
|
B:LEU674
|
2.3
|
84.1
|
1.0
|
OD1
|
B:ASP531
|
2.3
|
80.6
|
1.0
|
OD1
|
B:ASP529
|
2.4
|
70.1
|
1.0
|
N
|
B:LEU674
|
3.2
|
81.4
|
1.0
|
C
|
B:LEU530
|
3.3
|
79.2
|
1.0
|
C
|
B:LEU674
|
3.3
|
79.5
|
1.0
|
CG
|
B:ASP673
|
3.5
|
77.1
|
1.0
|
CG
|
B:ASP531
|
3.6
|
72.0
|
1.0
|
CG
|
B:ASP529
|
3.7
|
80.9
|
1.0
|
NZ
|
B:LYS106
|
3.8
|
67.9
|
1.0
|
CA
|
B:LEU674
|
3.8
|
79.2
|
1.0
|
C
|
B:ASP673
|
3.8
|
77.0
|
1.0
|
ND2
|
B:ASN537
|
3.9
|
88.5
|
1.0
|
N
|
B:ASP531
|
4.0
|
80.2
|
1.0
|
CA
|
B:ASP531
|
4.0
|
75.8
|
1.0
|
CA
|
B:ASP673
|
4.1
|
73.0
|
1.0
|
N
|
B:LEU530
|
4.1
|
72.3
|
1.0
|
C
|
B:ASP529
|
4.2
|
75.5
|
1.0
|
CA
|
B:LEU530
|
4.3
|
72.4
|
1.0
|
OD2
|
B:ASP673
|
4.4
|
69.9
|
1.0
|
CB
|
B:ASP531
|
4.4
|
73.6
|
1.0
|
CB
|
B:ASP673
|
4.4
|
77.9
|
1.0
|
OD2
|
B:ASP529
|
4.4
|
86.2
|
1.0
|
O
|
B:LEU535
|
4.4
|
91.2
|
1.0
|
N
|
B:VAL675
|
4.5
|
75.3
|
1.0
|
OD2
|
B:ASP531
|
4.5
|
66.7
|
1.0
|
CA
|
B:ASP529
|
4.6
|
80.3
|
1.0
|
CB
|
B:LEU674
|
4.6
|
75.3
|
1.0
|
O
|
B:ASP529
|
4.6
|
72.3
|
1.0
|
O
|
B:ASP673
|
4.7
|
79.7
|
1.0
|
CB
|
B:ASP529
|
4.7
|
81.2
|
1.0
|
CD2
|
B:LEU535
|
4.7
|
1.0
|
1.0
|
CA
|
B:VAL675
|
4.9
|
73.6
|
1.0
|
|
Calcium binding site 4 out
of 4 in 4bty
Go back to
Calcium Binding Sites List in 4bty
Calcium binding site 4 out
of 4 in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca1764
b:81.1
occ:1.00
|
OE1
|
B:GLU667
|
2.3
|
0.2
|
1.0
|
O
|
B:PHE663
|
2.3
|
83.0
|
1.0
|
OE2
|
B:GLU572
|
2.4
|
79.8
|
1.0
|
OD1
|
B:ASN665
|
2.4
|
94.1
|
1.0
|
OE1
|
B:GLU572
|
3.1
|
73.6
|
1.0
|
CD
|
B:GLU572
|
3.1
|
77.2
|
1.0
|
NZ
|
B:LYS638
|
3.2
|
98.1
|
1.0
|
C
|
B:PHE663
|
3.3
|
76.5
|
1.0
|
CD
|
B:GLU667
|
3.4
|
0.8
|
1.0
|
CG
|
B:ASN665
|
3.5
|
86.6
|
1.0
|
OE1
|
B:GLU641
|
3.6
|
84.3
|
1.0
|
OE2
|
B:GLU641
|
3.7
|
73.0
|
1.0
|
ND2
|
B:ASN665
|
3.9
|
87.1
|
1.0
|
OE2
|
B:GLU667
|
3.9
|
0.9
|
1.0
|
CA
|
B:PHE663
|
4.0
|
80.7
|
1.0
|
CD
|
B:GLU641
|
4.1
|
81.9
|
1.0
|
CG2
|
B:THR635
|
4.3
|
81.8
|
1.0
|
N
|
B:ILE664
|
4.4
|
76.8
|
1.0
|
CE
|
B:LYS638
|
4.4
|
93.2
|
1.0
|
CD
|
B:LYS638
|
4.4
|
89.7
|
1.0
|
N
|
B:GLN636
|
4.5
|
71.8
|
1.0
|
OG1
|
B:THR635
|
4.5
|
75.5
|
1.0
|
O
|
B:GLN636
|
4.5
|
82.0
|
1.0
|
CB
|
B:GLN636
|
4.6
|
88.2
|
1.0
|
CG
|
B:GLU667
|
4.6
|
88.0
|
1.0
|
CG
|
B:GLU572
|
4.6
|
79.0
|
1.0
|
CB
|
B:PHE663
|
4.7
|
85.0
|
1.0
|
CA
|
B:ILE664
|
4.7
|
84.0
|
1.0
|
CB
|
B:GLU667
|
4.8
|
83.5
|
1.0
|
O
|
B:ASP662
|
4.8
|
0.9
|
1.0
|
CB
|
B:THR635
|
4.9
|
78.8
|
1.0
|
N
|
B:ASN665
|
4.9
|
83.4
|
1.0
|
CB
|
B:ASN665
|
5.0
|
77.0
|
1.0
|
|
Reference:
E.Bligt-Linden,
M.Pihlavisto,
I.Szatmari,
Z.Otwinowski,
D.J.Smith,
L.Lazar,
F.Fulop,
T.A.Salminen.
Novel Pyridazinone Inhibitors For Vascular Adhesion Protein- 1 (Vap-1): Old Target - New Inhibition Mode. J.Med.Chem. V. 56 9837 2013.
ISSN: ISSN 0022-2623
PubMed: 24304424
DOI: 10.1021/JM401372D
Page generated: Sat Jul 13 22:50:37 2024
|